Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020 - 2025)
Monopar Therapeutics' (MNPR) quarterly Total Non-Current Liabilities came in at $2.9 million in Q4 2025, down 44.99% year-on-year from $5.3 million in Q4 2024, and up 9.5% quarter-over-quarter from $2.6 million in Q3 2025.
Monopar Therapeutics (MNPR) Total Non-Current Liabilities (2020 - 2025) Analysis & Trends
Monopar Therapeutics has disclosed Total Non-Current Liabilities across 3 years of filings, most recently posting $2.9 million for Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at $2.9 million, down 44.99% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.9 million (down 44.99% YoY), and the FY2025 annual result was $2.9 million, down 44.99% from the prior year.
- Total Non-Current Liabilities came in at $2.9 million for Q4 2025 at Monopar Therapeutics, up from $2.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $5.3 million in Q4 2024 to a low of $1.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 64.76 Mn |
| 10 | Monopar Therapeutics | 441.25 Mn | 441.25 Mn | - | 2.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.89 Mn |
| Sep 30, 2025 | 2.64 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 5.25 Mn |
| Sep 30, 2020 | 54,628.00 |
| Jun 30, 2020 | 75,021.00 |